Shu, V.A.; Eni, D.B.; Ntie-Kang, F. A Survey of Isatin Hybrids and Their Biological Properties. Molecular Diversity 2024, doi:10.1007/s11030-024-10883-z.
Shu, V.A.; Eni, D.B.; Ntie-Kang, F. A Survey of Isatin Hybrids and Their Biological Properties. Molecular Diversity 2024, doi:10.1007/s11030-024-10883-z.
Shu, V.A.; Eni, D.B.; Ntie-Kang, F. A Survey of Isatin Hybrids and Their Biological Properties. Molecular Diversity 2024, doi:10.1007/s11030-024-10883-z.
Shu, V.A.; Eni, D.B.; Ntie-Kang, F. A Survey of Isatin Hybrids and Their Biological Properties. Molecular Diversity 2024, doi:10.1007/s11030-024-10883-z.
Abstract
The emergence of diverse infections worldwide, which is a serious global threat to human existence, necessitate the urgent development of novel therapeutic candidates that can combat these diseases with efficacy. Isatin, a secondary metabolite from tryptophan is considered a privileged scaffold and favorable pharmacophore with a unique structural moiety and varied chemical and biological properties resulting in its widespread applications by medicinal chemists. Molecular hybridization is one of the most common and important techniques use in the synthesis of their bioactive hybrids in drug discovery. This review containing published articles from 2005 to 2022 focuses on isatin hybrids which have been synthesized and reported in the literature alongside a discussion on their biological properties. The purpose of this review is to set up the direction for the design and development of isatin-hybrids with tailored biological properties as effective therapeutic candidates inspired by nature.
Chemistry and Materials Science, Medicinal Chemistry
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
